Clinical Trial Supply Global Blog
Pharma IQ wanted to analyse this, along with how the industry's challenges have changed within the past 12 months with our survey "Global Clinical Trial Logistics 2019" - the results of which have just been published here.
Pharma Logistics IQ sat down with Paul O'Connor, Global Vice President Quality, Almac, to discuss the potential effects of Brexit on the industry and how ALMAC is preparing for these changes.
In the clinical trial supply market there is continued pressure on the pharmaceutical industry to optimise the clinical supply process from end to end. With this, it is clear that the need for lean process development continues to drive clinical supply experts in this marketplace.
This year we return for the 9th annual Clinical Trial Supply Forum as we focus on the theme of LEAN. GLOBAL. END TO END.